Nephro-Urology Monthly

Published by: Kowsar

The Role of Reticulocyte Hemoglobin Content in the Management of Iron Deficiency Anemia in Patients on Hemodialysis

Abdul Halim Abdul Gafor 1 , * , Ravih Subramaniam 1 , Firdaus Hadi 1 , Rizna Cader 1 , Kong Wei Yen 1 , Rozita Mohd 1 and Shamsul Azhar Shah 1
Authors Information
1 Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia
Article information
  • Nephro-Urology Monthly: May 2018, 10 (3); e65629
  • Published Online: April 1, 2018
  • Article Type: Research Article
  • Received: January 17, 2018
  • Accepted: March 7, 2018
  • DOI: 10.5812/numonthly.65629

To Cite: Abdul Gafor A H, Subramaniam R, Hadi F, Cader R, Wei Yen K, et al. The Role of Reticulocyte Hemoglobin Content in the Management of Iron Deficiency Anemia in Patients on Hemodialysis, Nephro-Urol Mon. 2018 ; 10(3):e65629. doi: 10.5812/numonthly.65629.

Abstract
Copyright © 2018, Nephro-Urology Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Kidney Disease Outcomes Quality I. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43(5 Suppl 1):S1-290. [PubMed: 15114537].
  • 2. Macdougall IC. Poor response to erythropoietin: practical guidelines on investigation and management. Nephrol Dial Transplant. 1995;10(5):607-14. [PubMed: 7566570].
  • 3. Nissenson AR. Achieving target hematocrit in dialysis patients: new concepts in iron management. Am J Kidney Dis. 1997;30(6):907-11. [PubMed: 9398140].
  • 4. National Kidney Foundation anemia working group . IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis. 2001;37(1 Suppl 1):S182-238. [PubMed: 11229970].
  • 5. Kalantar-Zadeh K, Rodriguez RA, Humphreys MH. Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrol Dial Transplant. 2004;19(1):141-9. [PubMed: 14671049].
  • 6. Fishbane S, Galgano C, Langley RJ, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int. 1997;52(1):217-22. [PubMed: 9211366].
  • 7. Mast AE, Blinder MA, Lu Q, Flax S, Dietzen DJ. Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood. 2002;99(4):1489-91. [PubMed: 11830506].
  • 8. Brugnara C, Laufer MR, Friedman AJ, Bridges K, Platt O. Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy. Blood. 1994;83(10):3100-1. [PubMed: 8180408].
  • 9. Karagulle M, Gunduz E, Sahin Mutlu F, Olga Akay M. Clinical significance of reticulocyte hemoglobin content in the diagnosis of iron deficiency anemia. Turk J Haematol. 2013;30(2):153-6. doi: 10.4274/Tjh.2012.0107. [PubMed: 24385778].
  • 10. Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol. 2006;28(5):303-8. doi: 10.1111/j.1365-2257.2006.00812.x. [PubMed: 16999719].
  • 11. Jeremiah PN, Cheak BB, Ahmad GB, Kun LS. Management of anemia in patients on dialysis. 2013. 16 p.
  • 12. Macdougall IC. Monitoring of iron status and iron supplementation in patients treated with erythropoietin. Curr Opin Nephrol Hypertens. 1994;3(6):620-5. [PubMed: 7881986].
  • 13. Rocha LA, Barreto DV, Barreto FC, Dias CB, Moyses R, Silva MR, et al. Serum ferritin level remains a reliable marker of bone marrow iron stores evaluated by histomorphometry in hemodialysis patients. Clin J Am Soc Nephrol. 2009;4(1):105-9. doi: 10.2215/CJN.01630408. [PubMed: 18842949].
  • 14. Saito M, Tsuchiya K, Ando M, Akiba T, Nihei H. [Measuring the content of reticulocyte hemoglobin (CHr) in predialysis chronic renal failure (CRF) patients]. Nihon Jinzo Gakkai Shi. 2003;45(5):430-8. [PubMed: 14509218].
  • 15. Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006;1 Suppl 1:S4-8. doi: 10.2215/CJN.01490506. [PubMed: 17699374].
  • 16. Adhikary L, Acharya S. Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy. JNMA J Nepal Med Assoc. 2011;51(183):133-6. [PubMed: 22922860].
  • 17. Charytan C, Levin N, Al-Saloum M, Hafeez T, Gagnon S, Van Wyck DB. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. Am J Kidney Dis. 2001;37(2):300-7. doi: 10.1053/ajkd.2001.21293. [PubMed: 11157370].
  • 18. Sunder-Plassmann G, Horl WH. Importance of iron supply for erythropoietin therapy. Nephrol Dial Transplant. 1995;10(11):2070-6. [PubMed: 8643170].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments